Lovastatin

洛伐他汀

Report date: 2026/04/27 20:02:09
NME

Base Information

Drug NameLovastatin
Drug Alias NameLovastatine洛伐它汀罗伐他丁Monakolin KLovastatinum +[22] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitors
TargetsHMG-CoA reductase
Therapy Area/IndicationsJaundiceHypercholesterolemiaHyperlipidemias +[26] 
Global Approved IndicationsHypercholesterolemiaHyperlipidemiasCoronary Disease
Approved Indications in ChinaHypercholesterolemiaHyperlipidemias
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesApotex IncVanderbilt UniversityZhejiang Ruibang Laboratories
Inactive CompaniesWashington University School Of MedicineStanford UniversityUniversity Of Antioquia +[19] 
Active IndicationsHypercholesterolemiaHyperlipidemiasNeurofibromatosis 1
Inactive IndicationsJaundiceDyslipidemiasSmith-Lemli-Opitz Syndrome +[23] 

Other Information

ATC CodeC10AA02
Related LinksWikipediaDrugBankKEGG